Company Ilsung Is Co., Ltd.

A003120

KR7003120003

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 15/05/2024 BST			5-day change	1st Jan Change
19,600 ^KRW	-0.56%		-1.21%	-17.12%

2023	Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	CI

Ilsung IS Co Ltd, formerly Ilsung Pharmaceutical Co Ltd, is a Korea-based company mainly engaged in the pharmaceuticals manufacture and sale business. The Companyâs products consist of penicillin antibiotics, contrast mediums, digestive drugs, cardiovascular agents, antihistamines, anti-diabetics, bone disease drugs, analgesics, muscle relaxants, anesthetics, skin disease drugs, cardiovascular drugs, psychiatry drugs, antivirals, antipyretics and others. The Company distributes its products through wholesalers, hospitals, pharmacies and others. The Company also provides consignment production services.

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	61,248	100.0 %	78,053	100.0 %	+27.44%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	61,248	100.0 %	78,053	100.0 %	+27.44%

Managers	Title	Age	Since
Jong-Wook Yoon CEO	Chief Executive Officer	38	-
Suk-Keun Yoon CEO	Chief Executive Officer	68	-
Hye-Suk Na BRD	Director/Board Member	57	-
Jong-Ho Yoon BRD	Director/Board Member	41	-
Duk-Keun Yoon PRN	Corporate Officer/Principal	64	-

Members of the board	Title	Age	Since
Suk-Keun Yoon CEO	Chief Executive Officer	68	-
Duk-Keun Yoon PRN	Corporate Officer/Principal	64	-
Jong-Ho Yoon BRD	Director/Board Member	41	-
Jong-Wook Yoon CEO	Chief Executive Officer	38	-
Seong-Yeol Lee BRD	Director/Board Member	63	-
Chang-Wan Son BRD	Director/Board Member	50	-
Young-Min Kim BRD	Director/Board Member	47	-
Hye-Suk Na BRD	Director/Board Member	57	-
Sung-Won Yoon BRD	Director/Board Member	61	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	13,300,000	530,678 ( 3.990 %)	6,484,327 ( 48.75 %)	3.990 %

Name	Equities	%	Valuation
ILSUNG IS CO., LTD. 48.75 %	6,484,327	48.75 %	93 M ₩
Suk-Keun Yoon 20.88 %	2,777,010	20.88 %	40 M ₩
Hyung-jin Yoon 8.026 %	1,067,410	8.026 %	15 M ₩
Daejung Scholarship Foundation 4.217 %	560,875	4.217 %	8 M ₩
Duk-Keun Yoon 4.150 %	551,970	4.150 %	8 M ₩
Pine Tree Investment & Management Co., Ltd. 1.708 %	227,180	1.708 %	3 M ₩
Jong-hee Yoon 0.2339 %	31,115	0.2339 %	448 006 ₩
Ji-seo Yoon 0.2312 %	30,755	0.2312 %	442 822 ₩
Jong-hyeon Yoon 0.2273 %	30,225	0.2273 %	435 191 ₩
Jong-Ho Yoon 0.2260 %	30,060	0.2260 %	432 815 ₩

Name	Equities	%	Valuation
ILSUNG IS CO., LTD. 48.75%	6,484,327	48.75%	93,363,804 $

Ilsung Pharmaceutical Co., Ltd.

9 Wonhyo-ro 84-gil Yongsan-gu

04315, Seoul

http://www.ilsung-ph.co.kr

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
ILSUNG IS CO., LTD.	-17.12%	102M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.98%	43.92B
OTSUKA HOLDINGS CO., LTD.	+24.56%	23.09B
SANDOZ GROUP AG	+19.25%	15.35B
CIPLA LIMITED	+14.03%	13.61B
ZYDUS LIFESCIENCES LIMITED	+46.40%	12.02B
ONO PHARMACEUTICAL CO., LTD.	-10.14%	7B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.6B

Generic Pharmaceuticals